CAPILLARYS IMMUNOTYPING, MODEL 2100— 510(k) K082085

Substantially Equivalent

Sebia

FDA 510(k) clearance K082085 for CAPILLARYS IMMUNOTYPING, MODEL 2100, Substantially Equivalent on 2009-04-17. Applicant: Sebia.

Clearance details

Applicant
Sebia
Product code
Code CFF
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Norcross, GA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.